Biotech

Domainex and Pharmacelera Partner to Advance AI-Driven Drug Discovery for Transmembrane Proteins

Collaboration integrates quantum mechanics-based modelling with cutting-edge experimental platforms to accelerate hit discovery for GPCRs and ion channels.

Qureight AI to Power Calluna’s Phase 2 IPF Study

AI-powered 3D lung imaging to accelerate assessment of CAL101, a first-in-class antibody targeting a key driver of fibrosis.

International Team to Build First Fully Synthetic Chloroplast Genomes

Camena Bioscience and Constructive Bio are partnering with global researchers to create the first fully synthetic chloroplast genomes.

Atelerix Appoints Industry Heavyweights to Board as It Gears Up for Global Expansion

Atelerix has appointed biotech leaders Sunil Shah and Dr Catherine Elton to its Board to support the company’s global commercial expansion and scale-up of its innovative cell preservation technology.

Allogene Pivoting Lymphodepletion Strategy in ALPHA3 CAR‑T Trial Following Patient Death

Allogene Therapeutics has revised its ALPHA3 CAR T trial to use only standard lymphodepletion after a patient death linked to its investigational antibody.

Centauri Therapeutics Secures $5.1M Boost from CARB-X to Advance Novel Antimicrobial into Clinical Trials

The funding will help complete non-clinical safety and efficacy studies, setting up ABX-01 for a first-in-human clinical trial planned for early 2026.